Exacerbation history is associated with medication and appointment adherence in MS

Laura M Hancock1, Jared M Bruce, Sharon G Lynch

  • 1Department of Psychology, University of Missouri-Kansas City, Kansas City, MO 64110, USA.

Insights

Patients with active multiple sclerosis (MS) relapse are more likely to adhere to disease-modifying treatments. Stable MS patients may need interventions to improve medication and appointment adherence.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Disease-modifying treatments (DMTs) are crucial for managing multiple sclerosis (MS) by preventing relapses.
  • Understanding the link between MS disease activity and treatment adherence is vital for optimizing patient outcomes.
  • Limited research exists on how disease activity influences adherence to DMTs and healthcare appointments in MS.

Purpose of the Study:

  • To investigate the association between disease activity (annualized relapse rates) and adherence to medication and appointments in relapsing-remitting MS (RRMS).
  • To determine if past disease activity can predict future adherence to disease-modifying therapies.

Main Methods:

  • Retrospective analysis of exacerbation and appointment data in relapsing-remitting MS patients.
  • Utilizing historical data to predict adherence to disease-modifying treatments.
  • Examining correlations between annualized relapse rates, medication adherence, and appointment adherence.

Main Results:

  • Patients experiencing higher annualized relapse rates demonstrated better medication adherence (fewer missed doses) and appointment adherence.
  • Conversely, patients with stable disease activity were more prone to poor medication and appointment adherence.
  • A significant correlation was found: patients missing more appointments also missed more doses of their DMTs.

Conclusions:

  • Disease activity appears to be a significant factor influencing treatment adherence in multiple sclerosis.
  • Patients with stable or less active MS may represent a target population for interventions aimed at improving adherence to disease-modifying treatments.
  • Future research should focus on developing strategies to enhance immunotherapy adherence, particularly during symptom-free periods in RRMS.

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: